Reduced‐dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B‐cell acute lymphoblastic leukemia

Documenti analoghi

• Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐rearranged, therapy‐related acute lymphoblastic leukemia
  di: Sanila Sarkar, et al.
  Pubblicazione: (2024)
• Differential impact of asparaginase discontinuation on outcomes of children with T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma
  di: Hisashi Ishida, et al.
  Pubblicazione: (2024)
• Tyrosine kinase inhibitors with blinatumomab versus chemotherapy in Philadelphia‐positive acute B‐lymphoblastic leukemia
  di: Sebastian M. Stolz, et al.
  Pubblicazione: (2025)
• Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy
  di: Harmony Leroy, et al.
  Pubblicazione: (2024)
• PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells
  di: Delphine Lebon, et al.
  Pubblicazione: (2024)